Share it on:
Company Overview
Founded in 2015, PharmEasy is a leading online healthcare platform in India that provides a range of services, including medicine delivery, diagnostic tests, and telemedicine consultations. The company aims to make healthcare accessible and affordable through technology-driven solutions.
Key Highlights
- Founded: 2015
- Headquarters: Mumbai, India
- Business Model: E-commerce for pharmaceuticals, diagnostics, and healthcare services.
- Key Services:
- Medicine Delivery: Home delivery of prescription and over-the-counter medications.
- Diagnostics: Lab tests conducted at home with online reporting.
- Telemedicine: Online consultations with qualified healthcare professionals.
Financial Performance
- Revenue Growth: PharmEasy has seen significant growth in revenues, reaching approximately ₹1,200 crores in FY 2022, up from ₹500 crores in FY 2021.
- Profitability: The company aims to achieve profitability in the near future by optimizing operations and scaling its service offerings.
Future Plans
- Expansion: PharmEasy plans to expand its services to tier-2 and tier-3 cities to capture a larger customer base.
- Technology Investment: Increased investment in technology to enhance user experience and improve operational efficiencies.
- Partnerships: Forge partnerships with local pharmacies and healthcare providers to expand the product and service range.
- Diversification: Explore new healthcare-related services, such as health insurance and wellness programs.
Fundamentals
Metric | Value | Metric | Value |
---|---|---|---|
Current Price | ₹ 11 | P/B | 1.1 |
Debt to Equity | 0.57 | P/E Ratio | -3 |
Market Cap (in Cr.) | ₹ 6756 | PAN Number | AASCA1201E |
Face Value | 1 | EPS | -3.71 |
Book Value | 10 | ISIN | INE0DJ201029 |
ROE (%) | -37.25 | No. Of Shares (in Cr.) | 614.2 |
Promoters & Managements
Name | Designation |
---|---|
Dr. Dhaval Shah | Co-Founder, CBO |
Siddharth Shah | CEO |
Abhinav Jain Ranka | CFO |
Profit & Loss
Item | 2022 | 2023 |
---|---|---|
Revenue | 4544 | 6752 |
Cost of Material Consumed | 5342 | 5707 |
Gross Margins | 6.76 | 14.88 |
Change in Inventory | -229 | 61 |
Employee Benefit Expenses | 1459 | 1568 |
Other Expenses | 1502 | 938 |
EBITDA | -2345 | -1569 |
Operating Profit Margin (OPM) | -40.93% | -23.4% |
Other Income | -1185 | 47 |
Finance Cost | 258 | 520 |
Depreciation & Amortization (D&A) | 159 | 240 |
EBIT | -2504 | -1809 |
EBIT Margins | -43.71% | -26.98% |
Profit Before Tax (PBT) | -3977 | -2282 |
PBT Margins | -69.42% | -34.03% |
Tax | 22 | -4 |
Profit After Tax (PAT) | -3999 | -2278 |
Net Profit Margin (NPM) | -69.8% | -33.97% |
Earnings Per Share (Diluted) | -6.51 | -3.71 |
Financial Ratios
Financial Ratios | 2022 | 2023 |
---|---|---|
Operating Profit Margin (OPM) | -40.93% | -23.4% |
Net Profit Margin (NPM) | -69.8% | -33.97% |
Earnings Per Share (Diluted) | -6.51 | -3.71 |
Balance Sheet
Assets | 2022 | 2023 |
---|---|---|
Fixed Assets | 1025 | 913 |
CWIP (Capital Work in Progress) | 7.8 | 7 |
Investments | 438 | 437 |
Trade Receivables | 861 | 903 |
Inventory | 761 | 689 |
Other Assets | 8305.2 | 8393.6 |
Total Assets | 11398 | 11342.6 |
Liabilities | 2022 | 2023 |
---|---|---|
Share Capital | 614.2 | 614.2 |
Face Value (FV) | 1 | 1 |
Reserves | 6408.3 | 5501.4 |
Borrowings | 2585 | 3511 |
Trade Payables | 459 | 356 |
Other Liabilities | 1331.5 | 1360 |
Total Liabilities | 11398 | 11342.6 |
Cash Flow Statement
Cash Flow Items | 2022 | 2023 |
---|---|---|
Cash Generated From Operations | -2505 | -669 |
Tax | -84 | -61 |
Cash Flow From Operations | -2589 | -730 |
Purchase of PPE | -143 | -92 |
Sale of PPE | 5 | 4 |
Cash Flow From Investment | -5789 | -100 |
Borrowing | 2016 | 648 |
Dividend | 0 | 22.8 |
Equity | 6344 | 548 |
Other Financing | -55 | -363 |
Cash Flow from Financing | 8305 | 855.8 |
Net Cash Generated | -73 | 25.8 |
Cash at the Start | 230 | 157 |
Cash at the End | 157 | 182.8 |
Share Holding Pattern
Shareholder | 2022 | 2023 |
---|---|---|
Naspers Ventures B.V. | 13.24% | 13.24% |
Evermed Holdings Pte. Ltd | 6.45% | 6.45% |
MacRitchie Investments Pte. Ltd | 11.93% | 11.93% |
Frequently Asked Questions (FAQ)
Find answers to common questions, providing clarity and insights to address any queries on your mind.
Contact Us: Reach out to Unlistify to confirm availability and agree on a price.
Provide KYC: Submit your Client Master Report, PAN card, and a cancelled cheque.
Make Payment: Transfer funds to our designated bank account (RTGS/NEFT/IMPS/cheque). Ensure the payment originates from the same account where you want the shares credited.
Receive Shares: We’ll transfer the Kannur International Airport Ltd shares to your Demat account within 24 hours of payment confirmation.
Get a Quote: Unlistify will provide a buyback price for your Kannur International Airport Ltd shares.
Share Details: Submit your Client Master Report.
Transfer Shares: Transfer the Kannur International Airport Ltd shares to our Demat account using a DIS (Delivery Instruction Slip).
Receive Payment: We’ll transfer funds to your bank account within 24 hours of receiving the shares (RTGS/NEFT/IMPS/cheque). For security reasons, payment will only be made to the account linked to your Demat
DIS (Delivery Instruction Slip): A DIS is a form used to authorize the transfer of shares from your Demat account.
Methods:
Offline DIS: Fill out a physical DIS form with details like the ISIN number, quantity, price of your Kannur International Airport Ltd shares, and our account information. Submit this to your broker.
Online DIS: Some brokers offer online DIS systems for easier transfers.
Unlistify aims to make unlisted share investing accessible. The current minimum investment for Kannur International Airport Ltd Unlisted Shares is approximately 35,000 – 50,000 INR.
Limited Liquidity: Unlisted shares are not traded on public exchanges, making it potentially harder to find buyers when you want to sell.
Price Volatility: Prices can fluctuate more than listed shares due to less publicly available information.
Regulatory Changes: Regulations for unlisted shares can change, affecting their value and trading.
Company-Specific Risks: Each company has its own risks related to its industry, financials, and management.
No Guarantee of Listing: There’s no assurance that unlisted shares will ever be listed on a public exchange.
Market Leader: Unlistify is one of India’s fastest-growing unlisted share platforms.
Transparency: We provide clear information about each unlisted share, including potential risks.
Security: We prioritize the protection of your financial information.
Customer Support: Our team is dedicated to guiding you through the investment process.
Latest Funding: We consider the valuation from Kannur International Airport Ltd most recent funding round.
Comparable Companies: If there’s no recent funding, we analyze similar listed companies to estimate a fair value.
SEBI’s Influence: SEBI regulations do apply to some aspects of unlisted share trading, such as lock-in periods and transaction charges. However, there are no specific SEBI regulations for becoming an unlisted broker.
We aim for same-day transfer of Kannur International Airport Ltd Unlisted Shares to your Demat account after your payment is confirmed.
Tax Transition: Once your unlisted Kannur International Airport Ltd shares are listed and sold on an exchange, standard listed share tax rules apply.
Holding Period: Your holding period (for determining long-term vs. short-term capital gains tax) starts from the original unlisted purchase date.